1. Home
  2. COGT vs DPC Comparison

COGT vs DPC Comparison

Compare COGT & DPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

N/A

Current Price

$26.90

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Logo DPC Holdings PLC Ordinary Shares

DPC

DPC Holdings PLC Ordinary Shares

N/A

Current Price

$30.96

Market Cap

5.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
COGT
DPC
Founded
2014
1778
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.1B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
COGT
DPC
Price
$26.90
$30.96
Analyst Decision
Strong Buy
Buy
Analyst Count
12
5
Target Price
★ $55.82
$51.40
AVG Volume (30 Days)
★ 1.9M
1.7M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $7,871,000.00
N/A
Revenue This Year
N/A
$34.53
Revenue Next Year
$5,819.52
$15.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.36
$25.00
52 Week High
$43.73
$57.25

Technical Indicators

Market Signals
Indicator
COGT
DPC
Relative Strength Index (RSI) 36.08 47.29
Support Level N/A $25.12
Resistance Level $37.34 $35.21
Average True Range (ATR) 1.77 2.97
MACD -0.36 0.60
Stochastic Oscillator 6.38 55.32

Price Performance

Historical Comparison
COGT
DPC

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About DPC DPC Holdings PLC Ordinary Shares

DPC Holdings PLC is a manufacturer of complex precision cast components for aerospace engines and industrial gas turbines. It produces metal components and specialized products for aerospace and industrial applications and operates manufacturing facilities across multiple locations globally.

Share on Social Networks: